OLODUO

Država: Indonezija

Jezik: indonezijski

Izvor: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Preuzimanje Svojstava lijeka (SPC)
01-01-2020

Aktivni sastojci:

ROSUVASTATIN CALCIUM, OLMESARTAN MEDOXOMIL

Dostupno od:

DAEWOONG INFION - Indonesia

INN (International ime):

ROSUVASTATIN CALCIUM, OLMESARTAN MEDOXOMIL

Doziranje:

10.40 Mg /20.00 MG

Farmaceutski oblik:

TABLET SALUT SELAPUT

Jedinice u paketu:

DUS, 3 BLISTER @ 10 TABLET SALUT SELAPUT

Proizveden od:

DAEWOONG PHARMACEUTICAL CO.,LTD - Republic Of Korea

Datum autorizacije:

2019-09-28

Svojstava lijeka

                                OLODUO FILM-COATED TABLET
(Olmesartan medoxomil, Rosuvastatin Calcium)
COMPOSITION
Each tablet of Oloduo film-coated tablet 40/20 mg contains
Olmesartan medoxomil
‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥
40.0 mg
Rosuvastatin calcium
‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥
20.80 mg
(As Rosuvastatin 20 mg)
Each tablet of Oloduo film-coated tablet 20/10 mg contains
Olmesartan medoxomil
‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥
20.0 mg
Rosuvastatin calcium
‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥
10.40 mg
(As Rosuvastatin 10 mg)
DESCRIPTION
White to light yellow film-coated tablet
INDICATIONS & USAGE
Patients receiving olmesartan and rosuvastatin from separate
tablets may
receive Oloduo containing the same component doses.
This drug should not be used as initial therapy.

Olmesartan medoxomil
Treatment of essential hypertension

Rosuvastatin
-
Rosuvastatin
is
indicated
for
patients
with
primary
hypercholesteroleaemia
(type
IIa,
including
heterozygous
familial
hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct
to diet when response to diet and exercise is inadequate.
-
Rosuvastatin
reduces
elevated
LDL-cholesterol,
total
cholesterol,
triglycerides and ApoB, and increases HDL-cholesterol
DOSAGE & ADMINISTRATION
This drug should be administered to adults
Usual adult dose
Treatment should not be initiated with this combination
The recommended dosage of Oloduo is one tablet daily.
General considerations
Olmesartan/rosuvastatin
is
a
combination
product
targeting
concomitant
cardiovascular conditions hypertension and dyslipidemia.
The dosage range for olmesartan/rosuvastatin is 20 mg/10 mg to a
maximum
dose of 40 mg/20 mg once daily. Before treatment, the patient should
be
placed on a standard cholesterol lowering diet that should continue
during
treatment.
As a component of multip
                                
                                Pročitajte cijeli dokument
                                
                            

Upozorenja za pretraživanje vezana za ovaj proizvod

Pogledajte povijest dokumenata